Pfizer plans to implement a company-wide cost-reduction initiative to lower its cost base in 2007 and 2008, in an effort to provide more flexibility in the face of changing market conditions. This new initiative is in addition to the Adapt to Scale (AtS) initiative. By 2008, these savings will be more than $4 billion and as a result, the company expects an average annual growth to be in the high single digits over 2007-08, though revenues are expected to stay flat during that span. According to ...